Physician Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Sell
10,105
-417
-4% -$10.9K 0.03% 191
2026
Q1
$295K Buy
10,522
+997
+10% +$26.5K 0.04% 150
2025
Q4
$237K Buy
9,525
+418
+5% +$10.5K 0.03% 175
2025
Q3
$232K Buy
9,107
+121
+1% +$2.99K 0.03% 171
2025
Q2
$218K Buy
8,986
+363
+4% +$8.47K 0.03% 172
2025
Q1
$219K Sell
8,623
-58
-0.7% -$1.52K 0.04% 166
2024
Q4
$230K Sell
8,681
-251
-3% -$6.81K 0.04% 162
2024
Q3
$263K Sell
8,932
-1,200
-12% -$35K 0.05% 152
2024
Q2
$299K Buy
10,132
+166
+2% +$4.57K 0.06% 126
2024
Q1
$256K Sell
9,966
-605
-6% -$16.8K 0.05% 138
2023
Q4
$299K Buy
10,571
+509
+5% +$15.4K 0.07% 121
2023
Q3
$334K Buy
10,062
+540
+6% +$19.1K 0.09% 99
2023
Q2
$349K Buy
9,522
+91
+1% +$3.54K 0.09% 96
2023
Q1
$380K Buy
9,431
+100
+1% +$4.32K 0.1% 92
2022
Q4
$417K Sell
9,331
-527
-5% -$25.3K 0.11% 87
2022
Q3
$435K Buy
9,858
+100
+1% +$4.86K 0.13% 83
2022
Q2
$494K Hold
9,758
0.14% 78
2022
Q1
$485K Sell
9,758
-1,921
-16% -$99.7K 0.13% 88
2021
Q4
$651K Hold
11,679
0.17% 72
2021
Q3
$485K Buy
11,679
+500
+4% +$22.1K 0.13% 88
2021
Q2
$464K Sell
11,179
-807
-7% -$31.4K 0.13% 89
2021
Q1
$435K Buy
11,986
+1,700
+17% +$60.4K 0.14% 86
2020
Q4
$355K Sell
10,286
-227
-2% -$8.33K 0.12% 92
2020
Q3
$361K Hold
10,513
0.14% 86
2020
Q2
$383K Buy
10,513
+52
+0.5% +$1.77K 0.15% 82
2020
Q1
$360K Buy
10,461
+1,436
+16% +$48.9K 0.18% 71
2019
Q4
$337K Hold
9,025
0.15% 83
2019
Q3
$331K Buy
+9,025
New +$328K 0.16% 79

Other funds holding PFE

Physician Wealth Advisors's PFE Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Pfizer (PFE) stake by 4% in Q2 2026, selling an estimated $10.9K and leaving 10,105 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #191.

Physician Wealth Advisors first reported a position in PFE in Q3 2019 and has held it in 28 quarters since. The position peaked at $651K in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Physician Wealth Advisors held 10,105 shares of Pfizer worth $243K as of Q2 2026.
  • Physician Wealth Advisors sold 417 Pfizer shares in Q2 2026, an estimated $10.9K.
  • Pfizer made up 0.03% of Physician Wealth Advisors's portfolio in Q2 2026, its #191 holding.
  • Physician Wealth Advisors first reported a position in Pfizer in Q3 2019 and has held it in 28 quarters since.
  • Physician Wealth Advisors's Pfizer position peaked at $651K in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.